Stay updated on NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH website transition updates and says the agency is using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-27T06:33:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T05:55:52.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page otherwise remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T08:14:19.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating access restrictions or a site issue; as a result, sponsor, locations, eligibility criteria, and related study information are no longer visible and the page shows a standard error layout.
    Difference
    19%
    Check dated 2026-09-22T06:32:30.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now displays the updated revision label, replacing v3.6.5 with v3.6.6. This indicates an updated page version rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T23:14:36.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Updated the page revision from v3.6.4 to v3.6.5. This reflects a minor backend/template update and does not modify the study content or how the study is presented.
    Difference
    0.1%
    Check dated 2026-08-10T12:53:56.000Z thumbnail image

Stay in the know with updates to NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214 Plus Nivolumab in Sarcoma Clinical Trial page.